What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Histone Acetyltransferase: Function, Types, and Mechanism

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Introduction to Histone Acetyltransferases

What are Histone Acetyltransferases?

Histone acetyltransferases (HATs) are a family of enzymes that catalyze the transfer of an acetyl group from acetyl-coenzyme A (acetyl-CoA) to the ε-amino group of specific lysine residues on histone proteins. This post-translational modification is fundamental to chromatin biology, as it directly alters the physicochemical properties of the histone proteins that package DNA into the nucleus.

The core histones—H2A, H2B, H3, and H4—are small, highly basic proteins that assemble into an octamer around which DNA wraps to form the Histone Nucleosome, the fundamental repeating unit of chromatin. Each histone possesses an N-terminal "tail" domain that extends outward from the nucleosome core. These tails are rich in lysine and arginine residues, whose positive charges interact electrostatically with the negatively charged phosphate backbone of DNA. When a HAT acetylates a lysine residue, the acetyl group neutralizes the lysine's positive charge, weakening the histone–DNA interaction and promoting a more open, accessible chromatin conformation.

HATs are often referred to as "writers" in the context of the Histone Code hypothesis, which posits that combinations of post-translational modifications on histone tails serve as a regulatory language that dictates chromatin state and gene expression outcomes. The acetylation marks written by HATs are read by bromodomain-containing proteins and can be removed by histone deacetylases (HDACs), establishing a dynamic equilibrium that cells exploit for rapid transcriptional responses.

Role in Chromatin Remodeling

Chromatin exists in two broad states: euchromatin, which is loosely packed and transcriptionally permissive, and heterochromatin, which is densely compacted and generally transcriptionally silent. Histone acetylation is a hallmark of euchromatin. By neutralizing positive charges on histone tails, acetylation reduces the affinity between histones and DNA, allowing nucleosomes to slide or be evicted more readily. This process is not merely passive; acetylation also recruits ATP-dependent chromatin remodeling complexes, such as SWI/SNF, which use the energy of ATP hydrolysis to reposition nucleosomes along the DNA.

The net effect of histone acetylation is an increase in the accessibility of DNA to transcription factors, RNA polymerase II, and other regulatory proteins. This is why HAT activity is strongly correlated with transcriptional activation. However, as discussed later, acetylation is not a monolithic "on" switch; its effects depend on the specific lysine residues modified, the promoter context, and the reader proteins that interpret the marks.

Types of Histone Acetyltransferases

HATs are classified into several families based on sequence homology, structural folds, and substrate preferences. The three major families in eukaryotes are the GNAT family, the MYST family, and the p300/CBP family. Each family has distinct structural features, cellular localization patterns, and biological functions.

GNAT Family

The Gcn5-related N-acetyltransferase (GNAT) family is named after its founding member, Gcn5 (general control nonderepressible 5), first identified in yeast as a transcriptional coactivator. Other members include PCAF (p300/CBP-associated factor), Hat1, and Elp3.

Structurally, GNAT family members share a conserved catalytic core domain composed of a central β-sheet flanked by α-helices, a fold that binds acetyl-CoA and the histone substrate. The catalytic mechanism involves a conserved glutamate residue that acts as a general base, deprotonating the lysine ε-amino group to facilitate nucleophilic attack on the acetyl-CoA thioester bond.

GNAT family HATs are typically part of large multiprotein complexes. For example, yeast Gcn5 exists within the SAGA (Spt-Ada-Gcn5 acetyltransferase) complex, which contains more than 20 subunits and targets nucleosomal histones, whereas free Gcn5 can only acetylate free histones. This distinction is critical: many HATs require association with complex subunits to recognize nucleosomal substrates efficiently. In human cells, PCAF and Gcn5 are found in complexes such as STAGA and TFTC, which are involved in transcriptional regulation at specific promoters.

GNAT family members show a preference for histone H3 lysines, particularly K9 and K14, although they can also acetylate H4K8 and H4K16 with lower efficiency. Hat1, an exception, is a cytoplasmic HAT that acetylates newly synthesized H4 at K5 and K12 before its incorporation into chromatin during DNA replication.

MYST Family

The MYST family is named after its founding members: MOZ (monocytic leukemia zinc finger protein), Ybf2/Sas3, Sas2, and Tip60 (Tat-interactive protein 60). This family is characterized by a unique MYST domain that contains both a canonical acetyl-CoA binding motif and a zinc finger motif. The MYST domain is larger and more complex than the GNAT catalytic core, and it includes a conserved cysteine residue that coordinates a zinc ion, which is essential for structural stability.

MYST family HATs are versatile enzymes that acetylate both histone and non-histone substrates. Tip60, for instance, acetylates H4K5, H4K8, H4K12, and H4K16, as well as H2AK5, and is a key component of chromatin remodeling complexes involved in DNA repair and apoptosis. MOZ and MORF (MOZ-related factor) are involved in HOX gene regulation and hematopoiesis, and chromosomal translocations involving these genes are associated with acute myeloid leukemia.

Sas2 and Sas3 in yeast are involved in establishing and maintaining euchromatin at telomeres and silent mating-type loci. Sas2, in particular, is responsible for the H4K16 acetylation that demarcates the boundary between euchromatin and heterochromatin at telomeres, preventing the spread of heterochromatin into active regions.

p300/CBP Family

The p300/CBP family consists of two highly homologous proteins in humans: p300 (EP300) and CBP (CREB-binding protein, CREBBP). These are large proteins (~300 kDa) that function as global transcriptional coactivators. Unlike the GNAT and MYST families, p300/CBP have a unique catalytic domain that does not share sequence homology with other HATs. The domain contains a bromodomain, a PHD finger, and a catalytic core with a central β-sheet structure that binds acetyl-CoA.

p300/CBP are promiscuous acetyltransferases that can modify all four core histones, with a preference for H3K18, H3K27, H4K5, and H4K8. They also acetylate numerous non-histone proteins, including transcription factors such as p53, NF-κB, and STAT3, thereby regulating their activity, stability, and subcellular localization.

These enzymes are considered "master integrators" of cellular signaling because they interact with over 400 different proteins and are recruited to promoters by a wide array of transcription factors. p300/CBP are essential for embryonic development; homozygous knockout of either gene in mice is embryonic lethal. Their activity is tightly regulated by autoacetylation, phosphorylation, and interaction with cellular inhibitors such as the adenoviral oncoprotein E1A.

The following table summarizes the key features of the three major HAT families:

Feature	GNAT Family	MYST Family	p300/CBP Family
Representative members	Gcn5, PCAF, Hat1	Tip60, MOZ, Sas2	p300, CBP
Catalytic domain	GNAT core (β-sheet + α-helices)	MYST domain (with zinc finger)	Unique p300/CBP catalytic domain
Histone substrate preference	H3K9, H3K14; H4K5, H4K12 (Hat1)	H4K5, H4K8, H4K12, H4K16; H2AK5	H3K18, H3K27; H4K5, H4K8
Complex partners	SAGA, STAGA, TFTC	NuA4, TIP60 complex	Interacts with >400 proteins
Cellular localization	Nuclear (Gcn5, PCAF); cytoplasmic (Hat1)	Nuclear	Nuclear
Non-histone substrates	p53, Myc (PCAF)	p53, androgen receptor	p53, NF-κB, STAT3, many others

Mechanism of Histone Acetylation

Catalytic Reaction

The acetylation reaction catalyzed by HATs is a bisubstrate reaction involving acetyl-CoA and a lysine residue on a histone protein. The reaction proceeds through a ternary complex mechanism in which both substrates bind to the enzyme before catalysis occurs.

The chemical steps are as follows:

Binding: The HAT enzyme binds acetyl-CoA and the histone substrate. The histone lysine residue fits into a deep hydrophobic pocket in the enzyme's active site, while the acetyl-CoA binds in an adjacent channel.

Deprotonation: A conserved glutamate residue in the active site acts as a general base, abstracting a proton from the ε-amino group of the lysine side chain. This deprotonation converts the amino group into a potent nucleophile.

Nucleophilic attack: The deprotonated amino group attacks the carbonyl carbon of the acetyl-CoA thioester bond, forming a tetrahedral intermediate.

Collapse and product release: The tetrahedral intermediate collapses, breaking the thioester bond and releasing coenzyme A (CoA-SH). The acetyl group remains covalently attached to the lysine ε-amino group via an amide bond, and the acetylated histone product is released from the enzyme.

The overall reaction can be written as:

Acetyl-CoA + Histone-Lys-NH₃⁺ → CoA-SH + Histone-Lys-NH-COCH₃

The equilibrium of this reaction strongly favors acetylation because the hydrolysis of the thioester bond in acetyl-CoA is highly exergonic. The acetyl-CoA concentration in the nucleus is typically in the low micromolar range, and HATs have Km values for acetyl-CoA in the range of 1–10 μM, ensuring that the reaction is sensitive to cellular metabolic state. Indeed, acetyl-CoA levels fluctuate with nutrient availability, linking cellular metabolism to chromatin regulation.

Substrate Specificity

HAT substrate specificity is determined by several factors:

Primary sequence context: The amino acids flanking the target lysine influence recognition. For example, Gcn5 preferentially acetylates lysines followed by glycine and preceded by basic residues, as seen in the H3K14 context (KSTGGKAPR). The H3 tail sequence around K14 is particularly accessible, which may explain why it is a preferred substrate for many HATs.

Nucleosome versus free histone: Many HATs, such as recombinant Gcn5 alone, can only acetylate free histones, not histones assembled into nucleosomes. This is because the N-terminal tails of histones in a nucleosome are partially occluded by DNA. Association with complex partners, such as the SAGA complex, repositions the active site or alters the enzyme's conformation to allow nucleosomal substrate access. The SAGA complex contains a deubiquitinase module that removes ubiquitin from H2BK123, which is a prerequisite for efficient H3 acetylation by Gcn5 in vivo.

Histone tail accessibility: The Histone Structure dictates that the N-terminal tails are flexible and extend outward, but their accessibility varies depending on the nucleosome position, the presence of linker histones, and higher-order chromatin folding. H4K16, for example, is buried in the interface between nucleosomes in higher-order chromatin fibers and becomes accessible only when chromatin is decompacted.

Cross-talk with other modifications: Substrate specificity is also governed by pre-existing modifications. For instance, phosphorylation of H3S10 by kinases such as Aurora B enhances acetylation of H3K14 by Gcn5, a phenomenon known as "phospho-acetylation" cross-talk. Conversely, Histone Methylation at H3K9 can inhibit acetylation at nearby lysines by blocking HAT access.

Function of Histone Acetyltransferases in Gene Regulation

Transcriptional Activation

The primary function of HATs is to promote transcriptional activation. This occurs through two complementary mechanisms: chromatin decompaction and recruitment of transcriptional machinery.

Chromatin decompaction: As described earlier, acetylation neutralizes the positive charge on lysine residues, weakening histone–DNA interactions. This facilitates nucleosome remodeling and eviction, exposing promoter and enhancer regions to the transcriptional machinery. Acetylation of H3K56, located in the globular domain of H3 near the DNA entry-exit point of the nucleosome, is particularly important for nucleosome stability and is associated with transcriptionally active genes.

Recruitment of bromodomain proteins: Acetylated lysines serve as docking sites for proteins containing bromodomains, which are ~110-amino-acid modules that specifically recognize acetylated lysine residues. The bromodomain-containing protein BRD4, for example, binds acetylated H3 and H4 and recruits the positive transcription elongation factor b (P-TEFb), which phosphorylates RNA polymerase II to promote transcriptional elongation. Other bromodomain proteins, such as TAF1 (a subunit of TFIID), are components of the basal transcription machinery itself, directly linking acetylation to transcription initiation.

The sequence of events at a typical HAT-dependent promoter is as follows:

A sequence-specific transcription factor binds to an enhancer or promoter element.
The transcription factor recruits a HAT complex (e.g., SAGA or p300/CBP) to the locus.
The HAT acetylates nearby nucleosomal histones, primarily on H3 and H4 tails.
Acetylation loosens chromatin structure and creates binding sites for bromodomain-containing proteins.
ATP-dependent chromatin remodelers are recruited, repositioning or evicting nucleosomes.
The basal transcription machinery, including TFIID and RNA polymerase II, gains access to the promoter and initiates transcription.

Interaction with Transcription Factors

HATs are not passive enzymes that randomly acetylate chromatin; they are targeted to specific genomic loci through direct interactions with transcription factors. p300/CBP, for instance, interact with a vast array of DNA-binding transcription factors, including CREB (cAMP response element-binding protein), p53, NF-κB, and nuclear hormone receptors. These interactions are often ligand-dependent or signal-dependent, ensuring that HAT activity is deployed only when appropriate.

For example, in the cAMP signaling pathway, activation of protein kinase A leads to phosphorylation of CREB at Ser133. Phosphorylated CREB binds to CBP via its KIX domain, recruiting CBP to cAMP-responsive genes. CBP then acetylates histones at these promoters, activating transcription. Similarly, p53, upon DNA damage, is acetylated by p300/CBP at multiple lysine residues in its C-terminal domain, which enhances its sequence-specific DNA binding and transcriptional activity, and also at histone lysines at p53 target gene promoters.

HATs can also acetylate transcription factors themselves, modulating their activity. PCAF acetylates p53 at K320, which promotes p53's recruitment to certain target gene promoters. Acetylation of NF-κB p65 at K310 by p300/CBP is required for full transcriptional activity of this factor. These non-histone acetylation events expand the functional repertoire of HATs beyond chromatin remodeling.

Histone Acetyltransferases in DNA Repair and Other Processes

Role in DNA Repair

Histone acetylation is intimately involved in the DNA damage response (DDR). When DNA double-strand breaks (DSBs) occur, cells must relax chromatin at the break site to allow repair factors access to the damaged DNA. HATs are among the first enzymes recruited to DSBs.

The MYST family HAT Tip60 plays a central role in this process. Upon DNA damage, Tip60 is recruited to DSBs where it acetylates H4K16. This acetylation serves two purposes: it opens chromatin structure, and it facilitates the acetylation and activation of the kinase ATM (ataxia-telangiectasia mutated). ATM is a master regulator of the DDR that phosphorylates dozens of downstream targets, including histone H2AX (forming γ-H2AX), which marks the damage site and recruits additional repair factors.

p300/CBP are also recruited to sites of DNA damage, where they acetylate H3K18 and H3K27. This acetylation promotes the recruitment of the chromatin remodeler SNF2h and the nucleotide excision repair machinery. In the context of base excision repair (BER), the HAT activity of p300 is required for the acetylation of the DNA glycosylase OGG1, which enhances its enzymatic activity.

The role of HATs in DNA repair is not limited to DSBs. During nucleotide excision repair (NER), which removes bulky DNA adducts caused by UV radiation, the promoter of the p21 gene is acetylated by p300 in a p53-dependent manner, facilitating the transcriptional response to DNA damage. Additionally, global genome repair requires the acetylation of H3K9 and H3K14 at damaged sites, which is carried out by Gcn5.

Cell Cycle and Apoptosis

HATs are critical regulators of the cell cycle and programmed cell death. Their activity fluctuates during the cell cycle, and their substrates include both histones and cell cycle regulatory proteins.

During S phase, histone acetylation is required for the incorporation of newly synthesized histones into chromatin. Hat1, the cytoplasmic HAT, acetylates newly synthesized H4 at K5 and K12 in the cytoplasm. These acetylation marks are recognized by the chromatin assembly factor CAF-1, which deposits the new histones onto replicating DNA. The marks are subsequently removed by HDACs after nucleosome assembly, restoring the steady-state acetylation pattern.

In the G2/M transition, HATs such as Tip60 regulate the expression of genes required for mitosis, including cyclin B1 and Cdc2. Tip60 also acetylates the transcription factor E2F, which controls the expression of S-phase genes.

In apoptosis, HATs play a dual role. p300/CBP acetylate p53, stabilizing it and enhancing its transcriptional activity toward pro-apoptotic target genes such as Bax and Puma. However, during the execution phase of apoptosis, caspases cleave p300/CBP, generating fragments that have dominant-negative activity, which may help shut down transcription in dying cells. Tip60 is also cleaved by caspases during apoptosis, and its acetyltransferase activity is required for the apoptotic chromatin condensation that characterizes programmed cell death.

Methods Used to Study Histone Acetyltransferases

In Vitro Acetylation Assays

The most direct method to study HAT activity is the in vitro acetylation assay. In a typical assay, a purified HAT enzyme is incubated with a histone substrate (either free histones, nucleosomes, or a peptide corresponding to a histone tail) and radiolabeled or fluorescently labeled acetyl-CoA.

A standard protocol for a radioactive acetylation assay is as follows:

Prepare a reaction mixture containing 50 mM Tris-HCl (pH 8.0), 10% glycerol, 1 mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 mM sodium butyrate (an HDAC inhibitor), and 1 μg of histone substrate.
Add 0.5–1 μg of purified HAT enzyme.
Initiate the reaction by adding 0.1 μCi of [¹⁴C]-acetyl-CoA or [³H]-acetyl-CoA (specific activity ~50 mCi/mmol) to a final concentration of 10–50 μM.
Incubate at 30°C for 10–30 minutes.
Stop the reaction by adding SDS-PAGE sample buffer and boiling for 5 minutes.
Separate proteins by SDS-PAGE, stain with Coomassie Blue, and visualize incorporated radioactivity by autoradiography or phosphorimaging.

Quantitative analysis can be performed by spotting the reaction onto P81 phosphocellulose paper, washing away unincorporated acetyl-CoA, and measuring radioactivity by liquid scintillation counting.

For high-throughput screening, non-radioactive assays using fluorescently labeled acetyl-CoA analogs or antibodies specific to acetylated lysines (e.g., anti-acetyl-H3K9) in an ELISA format are commonly used.

Chromatin Immunoprecipitation (ChIP)

Chromatin immunoprecipitation is the gold standard for determining where HATs bind and where histone acetylation occurs in the genome. The principle is to cross-link proteins to DNA, fragment the chromatin, immunoprecipitate with an antibody against the protein or modification of interest, and then analyze the associated DNA.

A typical ChIP protocol for histone acetylation includes:

Cross-link cells with 1% formaldehyde for 10 minutes at room temperature, then quench with 125 mM glycine.
Lyse cells and sonicate chromatin to fragments of 200–600 base pairs.
Immunoprecipitate with an antibody specific to acetylated histone (e.g., anti-H3K9ac, anti-H4K16ac) or to a HAT protein (e.g., anti-p300).
Reverse cross-links by heating at 65°C for 4–6 hours, then purify DNA.
Analyze the DNA by quantitative PCR (qPCR) for candidate loci, or by high-throughput sequencing (ChIP-seq) for genome-wide analysis.

ChIP-seq has revealed that H3K27ac marks active enhancers and promoters, while H3K9ac is enriched at promoter regions of actively transcribed genes. These maps have been invaluable for understanding how HATs contribute to cell-type-specific gene expression programs.

Mass Spectrometry for Acetylation Sites

Mass spectrometry (MS) has revolutionized the study of histone post-translational modifications by enabling the unbiased identification and quantification of acetylation sites. The approach involves:

Histone extraction: Histones are acid-extracted from cells using 0.2 M H₂SO₄, followed by acetone precipitation.
Proteolytic digestion: Histones are digested with trypsin, which cleaves after arginine residues. Because trypsin does not cleave efficiently after acetylated lysines, the digestion generates peptides of predictable lengths that contain acetylation marks.
Propionylation: To improve detection, free lysine ε-amino groups are chemically propionylated before trypsin digestion, which prevents trypsin cleavage at unmodified lysines and generates "mass-tagged" peptides that distinguish acetylated from unacetylated lysines.
LC-MS/MS analysis: Peptides are separated by reverse-phase liquid chromatography and analyzed by tandem mass spectrometry. The mass shift of +42.0106 Da (for acetylation) or +56.0262 Da (for propionylation) identifies modified residues.
Data analysis: Software such as MaxQuant or Proteome Discoverer matches spectra to histone sequences and quantifies the relative abundance of each modification state.

This approach has identified dozens of acetylation sites on all core histones, including many on the globular domains that were previously unknown. Quantitative MS has also revealed that histone acetylation is highly dynamic, with distinct acetylation patterns associated with different cellular states.

Histone Acetyltransferases and Disease

HATs in Cancer

Given their central role in gene regulation, it is not surprising that HAT dysregulation is a common feature of cancer. Both loss-of-function and gain-of-function alterations contribute to tumorigenesis.

Loss-of-function mutations: p300 and CBP are bona fide tumor suppressors. Inactivating mutations in EP300 and CREBBP are found in a variety of cancers, including colorectal, gastric, breast, and lung cancers, as well as in hematological malignancies such as diffuse large B-cell lymphoma and acute lymphoblastic leukemia. These mutations often result in truncated proteins or point mutations in the catalytic domain, leading to haploinsufficiency or dominant-negative effects. Loss of p300/CBP activity impairs p53-mediated tumor suppression, disrupts DNA repair, and alters the expression of genes involved in cell cycle control and apoptosis.

Chromosomal translocations: The MYST family HATs MOZ and MORF are frequent targets of chromosomal translocations in acute myeloid leukemia (AML). The t(8;16)(p11;p13) translocation fuses MOZ to CBP, creating a chimeric protein with aberrant acetyltransferase activity. Similarly, MOZ-TIF2 and MORF-TIF2 fusions are found in AML. These fusion proteins retain the HAT domain but lose regulatory sequences, leading to constitutive acetylation of target genes and aberrant transcriptional programs that block differentiation and promote proliferation.

Amplification and overexpression: In some cancers, HATs are overexpressed. For example, Tip60 is overexpressed in certain breast and prostate cancers, and its activity is required for the growth of MYC-driven tumors. PCAF is overexpressed in hepatocellular carcinoma, and its inhibition suppresses tumor growth in preclinical models.

Therapeutic implications: The dependence of cancer cells on HAT activity has led to the development of HAT inhibitors as anticancer agents. Compounds such as C646 (a p300/CBP inhibitor) and NU9056 (a Tip60 inhibitor) have shown antitumor activity in preclinical studies. Conversely, the bromodomain inhibitor JQ1, which blocks the reading of acetylation marks by BRD4, has entered clinical trials for several cancers, demonstrating the therapeutic potential of targeting the acetylation pathway.

HATs in Neurological Disorders

The nervous system is particularly sensitive to perturbations in histone acetylation, and HAT dysfunction has been implicated in several neurological and psychiatric disorders.

Rubinstein-Taybi syndrome: This rare genetic disorder is caused by heterozygous mutations in CREBBP (in ~55% of cases) or EP300 (in ~8% of cases). Patients present with intellectual disability, growth retardation, distinctive facial features, and broad thumbs and toes. The disorder results from haploinsufficiency of CBP/p300, which impairs the transcriptional programs required for normal brain development and synaptic plasticity. Mouse models of Rubinstein-Taybi syndrome show deficits in long-term memory that can be rescued by HDAC inhibitors, which restore acetylation levels.

Huntington's disease: This neurodegenerative disorder is caused by an expanded CAG repeat in the huntingtin gene. Mutant huntingtin protein interacts with and inhibits CBP, leading to reduced histone acetylation and transcriptional dysregulation. Decreased H3K9ac and H4K16ac levels are observed in the striatum of Huntington's disease patients. HDAC inhibitors, which counteract the loss of HAT activity, have shown neuroprotective effects in animal models of the disease.

Alzheimer's disease: Reduced histone acetylation is observed in the hippocampus of Alzheimer's disease patients, correlating with cognitive decline. Amyloid-β oligomers, which are central to Alzheimer's pathology, can reduce CBP levels and activity. Conversely, overexpression of CBP in mouse models improves memory and synaptic plasticity. Environmental enrichment and exercise, which increase histone acetylation in the hippocampus, have been shown to ameliorate cognitive deficits in mouse models of Alzheimer's disease.

Addiction and depression: Chronic drug exposure and stress alter histone acetylation in brain reward regions. For example, cocaine exposure increases H3K9ac at the promoters of specific genes in the nucleus accumbens, a brain region central to addiction, through the recruitment of CBP. Conversely, chronic social defeat stress decreases H3K14ac in the nucleus accumbens, and HDAC inhibitors produce antidepressant-like effects in rodent models.

Common Pitfalls and Misconceptions

HATs vs. HDACs

A frequent source of confusion is the distinction between histone acetyltransferases and histone deacetylases. HATs add acetyl groups to histones, while HDACs remove them. The misconception often extends to their functional roles: students may assume that HATs always activate transcription and HDACs always repress it. While this is broadly true, there are important exceptions.

HDACs are not simply "transcriptional repressors." They are also required for gene activation in certain contexts. For example, HDAC1 and HDAC2 are recruited to active genes where they remove acetylation marks from gene bodies, which is necessary for proper transcriptional elongation. HDACs also deacetylate non-histone proteins, including transcription factors, and can activate or repress their targets depending on the specific substrate.

Conversely, HATs can contribute to gene repression in some contexts. Acetylation of H4K16, for example, inhibits the formation of higher-order chromatin structures, but it can also prevent the spreading of heterochromatin into euchromatic regions, which is a repressive function in the sense that it maintains boundaries. Additionally, acetylation of certain transcription factors can inhibit their activity; for instance, acetylation of the androgen receptor at specific lysines can reduce its transcriptional activity.

Acetylation and Gene Activation

Another common misconception is that histone acetylation always leads to gene activation. While acetylation is strongly associated with active transcription, the relationship is not absolute. Several caveats apply:

Acetylation is not sufficient for activation: Acetylation creates a permissive chromatin state, but it does not by itself initiate transcription. Many acetylated loci are not actively transcribed; they are merely "poised" for activation. Transcription requires the additional recruitment of transcription factors, RNA polymerase, and the basal machinery.

Acetylation marks are context-dependent: The effect of acetylation depends on the specific lysine residue modified and the genomic context. Acetylation of H3K27, for example, marks active enhancers, but acetylation of H3K9 can also be found at some repressed loci. The Histone Code is combinatorial; the presence of other modifications (e.g., methylation) can override or modify the effect of acetylation.

Acetylation can be repressive at some loci: At certain genes, acetylation of promoter-proximal nucleosomes can actually inhibit transcription by preventing the binding of repressive factors or by stabilizing nucleosomes in a configuration that blocks transcription start site access. This is relatively rare but demonstrates that the relationship between acetylation and transcription is not a simple binary switch.

Non-histone acetylation complicates interpretation: HATs acetylate many non-histone proteins, and the effects of these modifications are diverse. Acetylation of p53, for example, can activate or repress specific target genes depending on which lysine residues are modified. Thus, the overall effect of a HAT on gene expression reflects the sum of its histone and non-histone substrates.

Summary and Key Takeaways

Histone acetyltransferases are a diverse family of enzymes that play central roles in chromatin biology and gene regulation. They catalyze the transfer of acetyl groups from acetyl-CoA to lysine residues on histone tails, neutralizing positive charges and promoting a more open chromatin conformation. The three major families—GNAT, MYST, and p300/CBP—differ in their structure, substrate specificity, and biological functions, but all are essential for proper transcriptional regulation, DNA repair, and cell cycle control.

The mechanism of histone acetylation involves a conserved catalytic core that deprotonates the lysine ε-amino group and promotes nucleophilic attack on acetyl-CoA. Substrate specificity is determined by the primary sequence context, nucleosome accessibility, and cross-talk with other post-translational modifications.

HATs promote transcriptional activation by decompacting chromatin and recruiting bromodomain-containing proteins, but they also have important roles in DNA repair, cell cycle regulation, and apoptosis. Their dysregulation is implicated in cancer and neurological disorders, making them attractive therapeutic targets.

Frequently Asked Questions

What is a histone acetyltransferase example?

Gcn5 is a classic example of a histone acetyltransferase. It was first identified in yeast as a transcriptional coactivator and is the founding member of the GNAT family. In humans, PCAF (p300/CBP-associated factor) is a close homolog of Gcn5. Other well-known examples include p300, CBP, Tip60, MOZ, and Hat1.

What are the types of histone acetyltransferases?

Histone acetyltransferases are classified into three major families based on sequence homology and structural features: the GNAT family (including Gcn5, PCAF, and Hat1), the MYST family (including Tip60, MOZ, MORF, and Sas2), and the p300/CBP family (including p300 and CBP). Each family has distinct catalytic domains, substrate preferences, and associated protein complexes.

What is the mechanism of histone acetyltransferase?

Histone acetyltransferases catalyze the transfer of an acetyl group from acetyl-CoA to the ε-amino group of a lysine residue on a histone protein. The reaction involves deprotonation of the lysine amino group by a conserved glutamate residue, followed by nucleophilic attack on the acetyl-CoA thioester bond. The products are acetylated lysine and free coenzyme A.

What is the function of histone acetyltransferase?

The primary function of histone acetyltransferases is to acetylate lysine residues on histone proteins, which neutralizes their positive charge and weakens histone-DNA interactions. This promotes a more open chromatin structure that is accessible to the transcriptional machinery. HATs also acetylate non-histone proteins, including transcription factors, thereby regulating their activity.

Are histone acetyltransferases activators or repressors?

Histone acetyltransferases are primarily transcriptional activators, as histone acetylation is generally associated with active gene expression. However, they can also contribute to gene repression in specific contexts, and their effects on non-histone substrates can be either activating or repressing. The net effect depends on the specific enzyme, substrate, and genomic context.

How do histone acetyltransferases affect gene expression?

Histone acetyltransferases affect gene expression by modifying chromatin structure. Acetylation of histone tails neutralizes positive charges, reducing histone-DNA interactions and promoting chromatin decompaction. This allows transcription factors and RNA polymerase to access the DNA. Acetylated lysines also serve as binding sites for bromodomain-containing proteins that recruit additional transcriptional activators.

What is the difference between HAT and HDAC?

HATs (histone acetyltransferases) add acetyl groups to lysine residues on histones, while HDACs (histone deacetylases) remove them. HATs are generally associated with transcriptional activation because acetylation opens chromatin, while HDACs are generally associated with transcriptional repression because deacetylation promotes chromatin compaction. However, both enzymes have additional non-histone substrates, and their effects on gene expression are context-dependent.

Key Takeaways

Histone acetyltransferases (HATs) catalyze the transfer of acetyl groups from acetyl-CoA to lysine residues on histone proteins, neutralizing positive charges and loosening chromatin structure.
The three major HAT families are GNAT (Gcn5, PCAF), MYST (Tip60, MOZ), and p300/CBP, each with distinct catalytic domains, substrate preferences, and biological functions.
Histone acetylation promotes transcriptional activation by opening chromatin and recruiting bromodomain-containing proteins, but it is not sufficient for activation on its own.
HATs are also involved in DNA repair, cell cycle regulation, and apoptosis, and they acetylate numerous non-histone proteins.
HAT dysregulation is linked to cancer (through mutations, translocations, and overexpression) and neurological disorders (including Rubinstein-Taybi syndrome, Huntington's disease, and Alzheimer's disease).
HATs and HDACs have opposing enzymatic activities but overlapping and context-dependent effects on gene expression; acetylation does not always activate genes.
Key experimental methods for studying HATs include in vitro acetylation assays, chromatin immunoprecipitation (ChIP), and mass spectrometry-based proteomics.